Trials / Completed
CompletedNCT04069416
Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria
Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria in High Prevalence Young HCC Patients Country.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 241 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims to evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients.
Detailed description
Introduction: HEPATOCELLULAR CARCINOMA (HCC) is the second leading cause of cancer mortality worldwide. Living donor liver transplantation (LDLT) for HCC patients has emerged as a rewarding therapy for a cure and a successful alternative where a Deceased donor liver transplantation (DDLT) program is lacking. Therefore, trials for careful expansion to Milan criteria have been adopted. Aim of the study: To evaluate the impact of expanding criteria beyond Milan on tumor recurrence and patient survival that will help identify the best selection criteria for HCC transplanted patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | living donor liver transplantation | liver graft from a living donor |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2015-12-01
- Completion
- 2019-01-01
- First posted
- 2019-08-28
- Last updated
- 2019-08-28
Source: ClinicalTrials.gov record NCT04069416. Inclusion in this directory is not an endorsement.